UK health and life sciences group agrees new clinical trials transparency principles

28 May 2012

The Ethical Standards in Health and Life Sciences Group (ESHLSG), a partnership including the Association of the British Pharmaceutical Industry (ABPI), the General Medical Council and a number of Royal Colleges of medical practices, has published a new series of clinical trial transparency principles and facts.

This is the first time that leading health care professional bodies and senior representatives of the pharmaceutical industry have agreed to a joint approach on this critical issue. This is an important step forward in the on-going move across the entire research community to drive best practice in clinical research reporting. The ESHLSG Principles document was introduced at last week’s joint British Medical Journal (BMJ) and ABPI conference: Innovation in research methods and dissemination - ensuring best practice.

Will provide better access to data for researchers

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight



More Features in Biotechnology